1bzy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1bzy" size="450" color="white" frame="true" align="right" spinBox="true" caption="1bzy, resolution 2.00&Aring;" /> '''HUMAN HGPRTASE WITH...)
Line 1: Line 1:
-
[[Image:1bzy.gif|left|200px]]<br />
+
[[Image:1bzy.gif|left|200px]]<br /><applet load="1bzy" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1bzy" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1bzy, resolution 2.00&Aring;" />
caption="1bzy, resolution 2.00&Aring;" />
'''HUMAN HGPRTASE WITH TRANSITION STATE INHIBITOR'''<br />
'''HUMAN HGPRTASE WITH TRANSITION STATE INHIBITOR'''<br />
==Overview==
==Overview==
-
The structure of human HGPRT bound to the transition-state analog, immucillinGP and Mg2+-pyrophosphate has been determined to 2.0 A, resolution. ImmucillinGP was designed as a stable analog with the, stereoelectronic features of the transition state. Bound inhibitor at the, catalytic site indicates that the oxocarbenium ion of the transition state, is stabilized by neighboring-group participation from MgPPi and O5'. A, short hydrogen bond forms between Asp 137 and the purine ring analog. Two, Mg2+ ions sandwich the pyrophosphate and contact both hydroxyls of the, ribosyl analog. The transition-state analog is shielded from bulk solvent, by a catalytic loop that moves approximately 25 A to cover the active site, and becomes an ordered antiparallel beta-sheet.
+
The structure of human HGPRT bound to the transition-state analog immucillinGP and Mg2+-pyrophosphate has been determined to 2.0 A resolution. ImmucillinGP was designed as a stable analog with the stereoelectronic features of the transition state. Bound inhibitor at the catalytic site indicates that the oxocarbenium ion of the transition state is stabilized by neighboring-group participation from MgPPi and O5'. A short hydrogen bond forms between Asp 137 and the purine ring analog. Two Mg2+ ions sandwich the pyrophosphate and contact both hydroxyls of the ribosyl analog. The transition-state analog is shielded from bulk solvent by a catalytic loop that moves approximately 25 A to cover the active site and becomes an ordered antiparallel beta-sheet.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1BZY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with MG, IMU and POP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Hypoxanthine_phosphoribosyltransferase Hypoxanthine phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.8 2.4.2.8] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1BZY OCA].
+
1BZY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=MG:'>MG</scene>, <scene name='pdbligand=IMU:'>IMU</scene> and <scene name='pdbligand=POP:'>POP</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Hypoxanthine_phosphoribosyltransferase Hypoxanthine phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.8 2.4.2.8] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1BZY OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Hypoxanthine phosphoribosyltransferase]]
[[Category: Hypoxanthine phosphoribosyltransferase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Almo, S.C.]]
+
[[Category: Almo, S C.]]
-
[[Category: Furneaux, R.H.]]
+
[[Category: Furneaux, R H.]]
[[Category: Grubmeyer, C.]]
[[Category: Grubmeyer, C.]]
[[Category: Li, C.]]
[[Category: Li, C.]]
-
[[Category: Schramm, V.L.]]
+
[[Category: Schramm, V L.]]
[[Category: Shi, W.]]
[[Category: Shi, W.]]
-
[[Category: Tyler, P.C.]]
+
[[Category: Tyler, P C.]]
[[Category: IMU]]
[[Category: IMU]]
[[Category: MG]]
[[Category: MG]]
Line 38: Line 37:
[[Category: transition state]]
[[Category: transition state]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:16:18 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:00:59 2008''

Revision as of 10:01, 21 February 2008


1bzy, resolution 2.00Å

Drag the structure with the mouse to rotate

HUMAN HGPRTASE WITH TRANSITION STATE INHIBITOR

Contents

Overview

The structure of human HGPRT bound to the transition-state analog immucillinGP and Mg2+-pyrophosphate has been determined to 2.0 A resolution. ImmucillinGP was designed as a stable analog with the stereoelectronic features of the transition state. Bound inhibitor at the catalytic site indicates that the oxocarbenium ion of the transition state is stabilized by neighboring-group participation from MgPPi and O5'. A short hydrogen bond forms between Asp 137 and the purine ring analog. Two Mg2+ ions sandwich the pyrophosphate and contact both hydroxyls of the ribosyl analog. The transition-state analog is shielded from bulk solvent by a catalytic loop that moves approximately 25 A to cover the active site and becomes an ordered antiparallel beta-sheet.

Disease

Known diseases associated with this structure: HPRT-related gout OMIM:[308000], Lesch-Nyhan syndrome, 300322, OMIM:[308000]

About this Structure

1BZY is a Single protein structure of sequence from Homo sapiens with , and as ligands. Active as Hypoxanthine phosphoribosyltransferase, with EC number 2.4.2.8 Full crystallographic information is available from OCA.

Reference

The 2.0 A structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor., Shi W, Li CM, Tyler PC, Furneaux RH, Grubmeyer C, Schramm VL, Almo SC, Nat Struct Biol. 1999 Jun;6(6):588-93. PMID:10360366

Page seeded by OCA on Thu Feb 21 12:00:59 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools